Interpace Biosciences, Inc. (IDXG)

Interpace Biosciences Revenue

Interpace Biosciences had revenue of $12.30M in the quarter ending September 30, 2024, with 35.44% growth. This brings the company's revenue in the last twelve months to $44.89M, up 17.33% year-over-year. In the year 2023, Interpace Biosciences had annual revenue of $40.21M with 26.31% growth.

• Revenue (ttm): 44.89M
• Revenue Growth: +17.33%
• P/S Ratio: 0.11
• Revenue / Employee: 415.68K
• Employees: 108
• Market Cap: 5.06M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	40.21M	8.38M	26.31%
Dec 31, 2022	31.84M	-1.28M	-3.86%
Dec 31, 2021	33.12M	719.00K	2.22%
Dec 31, 2020	32.40M	8.18M	33.77%
Dec 31, 2019	24.22M	2.32M	10.61%